Neonatal emollient therapy and massage practices in Africa: a scoping review.
Keona J H BlanksMilton W MusabaLily RenKathy BurgoineDavid MukunyaAndrew ClarkeSarah WilliamsTewodros GebremichaelPeter WaiswaGary L DarmstadtPublished in: International health (2023)
There have been few reports from Africa on the use and health effects of emollient therapy for newborn infants. We aimed to describe neonatal skin care practices in Africa, and to illuminate opportunities to introduce evidence-based interventions to improve these practices. We conducted a scoping review of the quantitative and qualitative published peer-reviewed and grey literature in English on emollient use in Africa. Outcomes of interest included neonatal skin care practices, with a focus on the application of oils and other products to infant skin, including in association with bathing and massage. We screened 5257 articles and summarised findings from 23 studies-13 qualitative, nine quantitative and one mixed methods-that met our study criteria. Seven studies reported the use of emollients for perceived benefits, including thermal care, treatment for illness, promotion of growth and development, infection reduction, skin condition improvement, spirituality and lubrication to aid massage. Four studies reported the quantitative health impact of skin care product applications, including improvements in skin condition, neurodevelopment and bone growth, as well as a reduction in nosocomial infections. This review highlights opportunities for skin care intervention and future research on neonatal skin care practices in Africa.
Keyphrases
- healthcare
- soft tissue
- palliative care
- wound healing
- primary care
- quality improvement
- randomized controlled trial
- systematic review
- mental health
- public health
- affordable care act
- physical activity
- high resolution
- emergency department
- multiple sclerosis
- stem cells
- type diabetes
- mass spectrometry
- adipose tissue
- climate change
- multidrug resistant
- social support
- health information
- cystic fibrosis
- tyrosine kinase
- case control
- cell therapy
- current status
- methicillin resistant staphylococcus aureus
- study protocol
- bone marrow